Second-line drug therapy for osteoarthritis

dc.contributor.authorBrandt, Kenneth D.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2019-07-17T17:45:37Z
dc.date.available2019-07-17T17:45:37Z
dc.date.issued2001-03
dc.identifier.citationBrandt K. D. (2001). Second-line drug therapy for osteoarthritis. Clinical medicine (London, England), 1(2), 110–114. doi:10.7861/clinmedicine.1-2-110en_US
dc.identifier.urihttps://hdl.handle.net/1805/19894
dc.language.isoen_USen_US
dc.publisherRoyal College of Physiciansen_US
dc.relation.isversionof10.7861/clinmedicine.1-2-110en_US
dc.relation.journalClinical medicineen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectAnti-inflammatory agents -- non-steroidalen_US
dc.subjectAntirheumatic agentsen_US
dc.subjectMetalloendopeptidasesen_US
dc.subjectOsteoarthritisen_US
dc.titleSecond-line drug therapy for osteoarthritisen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
110.pdf
Size:
113.37 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: